🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this study is to assess serious adverse events associated with ...
Status
Completed
Location
CMIC Co., Ltd
Start Date
2022-11-15
Trial ID
NCT05894590
This study will collect information on the safety of BNT162b2 products for ...
Status
Active Not Recruiting
Location
Pfizer
Start Date
2022-03-18
Trial ID
NCT05032976
Treatments Being Tested
This study will enroll individuals who have: * Completed primary series of...
Status
Completed
Location
University of California, San Diego
Start Date
2021-12-06
Trial ID
NCT05077254
The objective of this study is to evaluate the safety, tolerability and imm...
Status
Unknown
Location
Al Kuwait Hospital (Al Baraha Hospital)
Start Date
2021-12-22
Trial ID
NCT05043311
The purpose of this study was to understand whether participants could moun...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-04-19
Trial ID
NCT04792567
Treatments Being Tested
For Phase 1 only. Additional information will be provided when Phase 2 is i...
Status
Unknown
Location
Center for Vaccine Development-Mali
Start Date
2022-06-02
Trial ID
NCT05490108
Treatments Being Tested
The primary goal for this study is to evaluate the safety and reactogenicit...
Status
Completed
Location
Synexus Clinical Research US Phoenix Southeast, Inc.
Start Date
2021-03-11
Trial ID
NCT04813796
AICOVI (Adaptive Immune Response to COVID-19 Vaccination) is a prospective ...
Status
Unknown
Location
University Medicine Greifswald
Start Date
2021-01-06
Trial ID
NCT04826770
This is a Phase 3, randomized, observer-blind study in healthy individuals....
Status
Completed
Location
Kaiser Permanente Oakland
Start Date
2021-02-15
Trial ID
NCT04713553
Treatments Being Tested
The scope of this Phase I/II study is to determine whether GLB-COV2-043 is ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-02-21
Trial ID
NCT05602961
Treatments Being Tested